Mubashir J. Mintoo
Jammu, JK 180001, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Correction to "Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model".
Journal: Journal of medicinal chemistry
Published: March 26, 2026
Synthesis of β-boswellic acid-amino acid conjugates for targeting KRASG13D mutant colon cancer.
Journal: European journal of medicinal chemistry
Published: September 24, 2025
Inhibition and degradation of NRAS with a pan-NRAS monobody.
Journal: Oncogene
Published: July 12, 2024
Intersectin - many facets of a scaffold protein.
Journal: Biochemical Society transactions
Published: August 15, 2023
Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy.
Journal: Molecular pharmaceutics
Published: May 31, 2022
In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067.
Journal: Journal of integrative medicine
Published: January 25, 2022
N-Terminomics Strategies for Protease Substrates Profiling.
Journal: Molecules (Basel, Switzerland)
Published: June 16, 2021
Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor.
Journal: Scientific reports
Published: April 04, 2021
A rohitukine derivative IIIM-290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells.
Journal: Molecular carcinogenesis
Published: November 16, 2020
Binary and ternary solid dispersions of an anticancer preclinical lead, IIIM-290: In vitro and in vivo studies.
Journal: International journal of pharmaceutics
Published: April 02, 2019
Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy.
Journal: Materials science & engineering. C, Materials for biological applications
Published: August 27, 2018
Last Updated: 09/26/2026